Inhibitex

Hepatitis C Remains A Hot Play

Hepatitis C Remains A Hot Play

Seeking Alpha

Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill

Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill

Bloomberg

Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.

Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.

Yahoo

Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause

Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause

Seeking Alpha

Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012

Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012

Seeking Alpha

Second confirmed bidder for Inhibitex bodes well for Idenix, says Wedbush

Second confirmed bidder for Inhibitex bodes well for Idenix, says Wedbush

Yahoo/Fly on the Wall

Inhibitex Auction Shows Battle for Hepatitis Drugs

Inhibitex Auction Shows Battle for Hepatitis Drugs

Minyanville

Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline

Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline

Seeking Alpha

Bristol-Myers Raised Inhibitex Offer 30%

Bristol-Myers Raised Inhibitex Offer 30%

Bloomberg

CEO Gaffe of the Week: Bristol-Myers Squibb

CEO Gaffe of the Week: Bristol-Myers Squibb

Motley Fool